Previous 10 | Next 10 |
2023-11-21 09:27:03 ET More on Nvidia, Roche, etc. Nvidia Q3 Earnings Preview: Know The Risks And The Reward Nvidia: Smooth Sailing Nvidia Fiscal Q3 Earnings Preview: Big Wave Surfing 4 stocks to watch on Tuesday: Nvidia, Abercrombie & Fitch and more ...
2023-11-15 11:22:19 ET More on ARKG, ARKK, etc. ARKK ETF: There Are Better Options Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble ARKK: Outlook For Cathie Wood's ARK Innovation ETF Cathie Wood's ARK Invest l...
2023-11-06 12:36:20 ET Summary Customers in the biopharma industry are cutting spending, creating a soft demand environment for Schrodinger's software and drug discovery services. Despite the recent share price spike, Schrodinger's valuation is still low when accounting for all of...
Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in the following conferences in November: Jefferies London Healthcare Conference: Fireside chat...
2023-11-06 08:00:00 ET Summary The S&P 500 was up 5.9% for the week, and is just 5.0% below the 2023 high watermark. The best performer last week was Blockchain, as Bitcoin continues to gain upward momentum. After several weeks of narrowing market participation, it now loo...
2023-11-04 09:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Better-than-expected labor productivity data for the U.S. economy reported on Nov. 2 was the reason behind the huge stock market rally that day. “Non-farm productivity, which mea...
Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that new data on SGR-1505, its investigational MALT1 inhibitor, and SGR-2921, its investigational CDC7 inhibitor, will be presented during...
2023-11-02 08:15:00 ET With the frothiness of the artificial intelligence (AI) craze in full swing, Schrödinger (NASDAQ: SDGR) is a biotech that investors should know about now. While many questions remain about the viability of its business model and its ability to grow in the...
2023-11-01 22:36:04 ET Schrödinger, Inc. (SDGR) Q3 2023 Results Earnings Conference Call November 1, 2023, 04:30 PM ET Company Participants Jaren Madden - Senior Vice President, Investor Relations and Corporate Communications Ramy Farid - President and Chief Exe...
2023-11-01 16:03:46 ET More on Schrödinger Schrodinger: Leading The AI Healthcare Revolution Schrodinger: More Than An AI Bubble Stock Schrodinger: A Computational Platform That Is Likely Becoming Obsolete Seeking Alpha’s Quant Rating on Schrö...
News, Short Squeeze, Breakout and More Instantly...
Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its second quarter 2024 financial results on Wednesday, July 31, 2024, after the financial markets close. The company will host a conference c...
2024-07-14 09:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-24 12:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...